• Berlin
  • Tackling Counterfeit Drugs: Risks and Precautions


Tackling Counterfeit Drugs: Risks and Precautions

Tackling Counterfeit Drugs: Risks and Precautions (Photo: Volodymyr Hryshchenko / unsplash)

Counterfeit medicines are on the rise worldwide. According to the World Health Organization, about 10 percent of medical products in circulation in low- and middle-income countries are substandard or counterfeit. The actual number of cases of counterfeit medicines being produced and distributed is likely to be much higher than estimated, as many cases of counterfeiting go undetected or unreported. Whether it’s a misrepresentation of the origin or the content, fake medicines can lead to treatment failure, adverse reactions, and even death. This article explores the risks associated with counterfeit drugs and the precautions necessary to mitigate those risks.

Understanding Counterfeit Drugs

Counterfeit drugs are defined as pharmaceutical products that are fraudulently mislabeled with respect to identity or source. This includes:

  • Drugs without active ingredients.
  • Drugs with incorrect quantities of active ingredients.
  • Drugs with fake packaging.
  • Drugs containing incorrect ingredients.

Risks of Counterfeit Drugs

Therapeutic Failure: When counterfeit drugs lack the essential active ingredients, patients do not receive the therapeutic benefits they need, which can lead to worsening of diseases or conditions.

Unintended Side Effects: These drugs may contain wrong or harmful ingredients which can lead to severe adverse reactions.

Antibiotic Resistance: Counterfeit antibiotics with substandard amounts of active ingredients can promote the growth of antibiotic-resistant bacteria.

Loss of Trust in Healthcare: When patients consume counterfeit drugs believing them to be genuine, their trust in health systems, health professionals, and genuine drug manufacturers diminishes.

Economic Impact: Fake medicines can result in economic losses for genuine manufacturers and can divert funds from the legitimate healthcare sector.

Precautions to Tackle Counterfeit Drugs

Supply Chain Integrity: Pharmaceutical companies should employ rigorous supply chain checks, including serialization and traceability, to ensure the authenticity of drugs.

Advanced Packaging: Techniques like holography, barcodes, tamper-evidence features, and special inks can be utilized to make counterfeiting more difficult.

Public Awareness: Public and patient education about the risks associated with counterfeit drugs can be a vital tool. Patients should be informed about checking packaging, expiration dates, and any changes in appearance or taste of medicines.

Regulation and Surveillance: National regulatory authorities must step up their monitoring and surveillance of drug markets. Routine inspections and market surveillance can detect and remove counterfeit products.

International Collaboration: Given the global nature of pharmaceutical supply chains, international cooperation is key. Countries can share data, intelligence, and best practices to jointly address the challenge.

Pharmacovigilance: Effective pharmacovigilance systems can help detect and analyze adverse drug reactions, providing early warnings about potentially counterfeit products.

Purchase from Reputable Sources: Patients should always purchase medicines from legitimate pharmacies and distributors. When buying online, patients should ensure the retailer is reputable and is licensed or accredited by the appropriate national authority. For example, the Netherlands-based online pharmacy Apomeds clearly displays all its certifications and quality marks to ensure consumer confidence.

Technology Adoption: Technological tools such as mobile apps, which can scan and verify the authenticity of drugs, can be instrumental.


The menace of counterfeit drugs is multi-faceted and requires collective action from manufacturers, regulators, healthcare professionals, and consumers. Vigilance, awareness, and a robust regulatory environment are crucial to curbing this threat and ensuring public health and safety.

Note: This article provides general guidance and understanding. Specific regulations and requirements might differ depending on the country or region. Always consult local regulatory authorities for precise guidelines.